Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole for Breast Cancer Prevention in High Risk Women
NCT00579826Phase 2Completed
- Start
- Oct 2006
- Primary completion
- Mar 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in breast cancer comparing Letrozole with Placebo (2 arms). Primary endpoint: Change in Proliferation Rate (Ki-67 by Immunocytochemistry) at 6 months. Started Oct 2006; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00579826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00579826.